$6.7M in federal grants awarded to develop tech to monitor, treat chronic eye diseases

Chi Hwan Lee leads the teams that are developing the patent-pending lenses, which can painlessly deliver therapeutic drugs or accurately measure intraocular pressure, or IOP. IOP is the only known modifiable risk factor for glaucoma.

Lee is the Leslie A. Geddes Associate Professor of Biomedical Engineering in Purdue’s Weldon School of Biomedical Engineering. He holds a joint appointment in the School of Mechanical Engineering and a courtesy appointment in the School of Materials Engineering.

Other researchers are Bryan Boudouris, Purdue’s associate vice president for research in strategic interdisciplinary research and the R. Norris and Eleanor Shreve Professor of Chemical Engineering in the Davidson School of Chemical Engineering; Shin Ae Park, assistant professor of ophthalmology in Purdue’s College of Veterinary Medicine; Pete Kollbaum, associate dean for research, director of the Borish Center for Ophthalmic Research and professor in Indiana University’s School of Optometry; and Dr. Yannis Paulus, associate professor of ophthalmology and visual sciences and biomedical engineering at Michigan Medicine.

Team members also included Jinyuan Zhang, a former Purdue postdoctoral student in biomedical engineering and now a health technologies research and development engineer at Apple, and Yumin Dai, a graduate student in the School of Materials Engineering. 

“Working on smart soft contact lenses allowed us to engage in top-tier interdisciplinary research, moving beyond theory to craft real-world solutions that aim to transform eye disease treatment,” Dai said. “We gained hands-on experience in biomedical engineering, materials science and clinical application, equipping us for future healthcare challenges. This project highlights our dedication to merging education with groundbreaking research, ensuring we’re prepared to make a real impact.” 

The National Eye Institute is one of the National Institutes of Health; the funding comes from the NIH Research Project Grant Program, or R01.

The innovation

Lee specializes in StickTronics, which are stickerlike items that contain electronics or smart technology. He develops wearable biomedical devices that continuously monitor and manage chronic diseases or health conditions unobtrusively.

Some traditional wearable tonometers — devices that measure pressure inside the eyes — are equipped with an integrated circuit chip. This increases contact lens thickness and stiffness compared with a typical commercial soft contact lens, in many cases causing discomfort for patients. The research team’s version is different.

“To address this unmet need, we developed a unique class of smart soft contact lenses built upon various commercial brands of soft contact lenses for continuous 24-hour IOP monitoring and potentially treatment, even during sleep at home,” Lee said.

“Our smart soft contact lenses retain the intrinsic lens features of lens power, biocompatibility, softness, transparency, wettability, oxygen transmissibility and overnight wearability. Having all these features at the same time is crucial to the success of translating the smart soft contact lenses into ocular disease care, but these features are lacking in current devices.” 

The NEI grants

Lee said the $6.7 million funding from the two NEI grants will further refine the smart soft contact lenses. Concurrently, clinical trials will be conducted in collaboration with Purdue’s College of Veterinary Medicine, the IU School of Optometry and Michigan Medicine to assess the lenses’ biosafety, usability, functionality, therapeutic effectiveness and durability.

“With the steadfast support from NEI, the successful completion of these projects will solidify our path toward introducing an innovative, closed-loop system for these smart contact lenses,” Lee said. “This system will enable simultaneous monitoring and drug delivery for a wide range of chronic ocular diseases.”

Lee disclosed the smart soft contact lenses innovation to the Purdue Innovates Office of Technology Commercialization, which has applied for a patent from the U.S. Patent and Trademark Office to protect the intellectual property.

About Purdue University

Purdue University is a public research institution demonstrating excellence at scale. Ranked among top 10 public universities and with two colleges in the top four in the United States, Purdue discovers and disseminates knowledge with a quality and at a scale second to none. More than 105,000 students study at Purdue across modalities and locations, including nearly 50,000 in person on the West Lafayette campus. Committed to affordability and accessibility, Purdue’s main campus has frozen tuition 13 years in a row. See how Purdue never stops in the persistent pursuit of the next giant leap — including its first comprehensive urban campus in Indianapolis, the new Mitchell E. Daniels, Jr. School of Business, and Purdue Computes — at https://www.purdue.edu/president/strategic-initiatives.

About Purdue Innovates Office of Technology Commercialization 

The Purdue Innovates Office of Technology Commercialization operates one of the most comprehensive technology transfer programs among leading research universities in the U.S. Services provided by this office support the economic development initiatives of Purdue University and benefit the university’s academic activities through commercializing, licensing and protecting Purdue intellectual property. In fiscal year 2023, the office reported 150 deals finalized with 203 technologies signed, 400 disclosures received and 218 issued U.S. patents. The office is managed by the Purdue Research Foundation, which received the 2019 Innovation & Economic Prosperity Universities Award for Place from the Association of Public and Land-grant Universities. In 2020, IPWatchdog Institute ranked Purdue third nationally in startup creation and in the top 20 for patents. The Purdue Research Foundation is a private, nonprofit foundation created to advance the mission of Purdue University. Contact otcip@prf.org for more information.